Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon
Nour D, Ismail M, Osman M, Rafei R, Kasir D, Dabboussi F, Colson P, Hamze M. Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon. PLOS ONE 2024, 19: e0302579. PMID: 38722969, PMCID: PMC11081361, DOI: 10.1371/journal.pone.0302579.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAntibodies, ViralBNT162 VaccineBreakthrough InfectionsCOVID-19COVID-19 VaccinesFemaleHumansLebanonMaleMiddle AgedSARS-CoV-2Spike Glycoprotein, CoronavirusVaccinationYoung AdultConceptsImmune responseAntibody titersAntibody levelsAnti-spike antibody levelsCharacteristics of immune responsesWaning immune responsesMultivariate logistic regression modelSARS-CoV-2 antibody titersLevel of antibody titerVaccinated patientsBNT162b2 vaccineUnivariate analysisLogistic regression modelsSputnik V vaccineBlood specimensPfizer-BioNTechVaccine doseImmune statusVaccinated adultsSARS-CoV-2InfectionNorth LebanonVaccineAstraZeneca vaccineTiters